Interaction of cationic antimicrobial peptides with Mycoplasma pulmonis

[1]  S. Rottem,et al.  The Phospholipid Profile of Mycoplasmas , 2012, Journal of lipids.

[2]  K. Dybvig,et al.  The Vsa Shield of Mycoplasma pulmonis Is Antiphagocytic , 2011, Infection and Immunity.

[3]  I. Lee,et al.  Antimicrobial Activity of a Halocidin-Derived Peptide Resistant to Attacks by Proteases , 2010, Antimicrobial Agents and Chemotherapy.

[4]  K. Dybvig,et al.  Identification of exopolysaccharide‐deficient mutants of Mycoplasma pulmonis , 2009, Molecular microbiology.

[5]  J. Marcos,et al.  Antimicrobial peptides: to membranes and beyond , 2009, Expert opinion on drug discovery.

[6]  R. Oliveira,et al.  Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis , 2007, Microbial cell factories.

[7]  A. Blanchard,et al.  Activities of Antimicrobial Peptides and Synergy with Enrofloxacin against Mycoplasma pulmonis , 2006, Antimicrobial Agents and Chemotherapy.

[8]  Takashi Shimizu,et al.  Antimicrobial Activity of Inducible Human β Defensin-2 Against Mycoplasma pneumoniae , 2006, Current Microbiology.

[9]  R. Hancock,et al.  Cationic host defense (antimicrobial) peptides. , 2006, Current opinion in immunology.

[10]  G. Jan,et al.  Resistance to Antimicrobial Peptides and Stress Response in Mycoplasma pulmonis , 2005, Antimicrobial Agents and Chemotherapy.

[11]  F. Tödtling,et al.  One size fits all?: Towards a differentiated regional innovation policy approach , 2005 .

[12]  S. Rottem.  Choline-containing lipids in mycoplasmas. , 2002, Microbes and infection.

[13]  F C Kafatos,et al.  Phylogenetic perspectives in innate immunity. , 1999, Science.

[14]  Y. Naot,et al.  Molecular Biology and Pathogenicity of Mycoplasmas , 1998, Microbiology and Molecular Biology Reviews.

[15]  Alan J. Waring,et al.  Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils , 1998, Antimicrobial Agents and Chemotherapy.

[16]  Steven D. Brown,et al.  In Vitro Antimicrobial Activity of MSI-78, a Magainin Analog , 1998, Antimicrobial Agents and Chemotherapy.

[17]  S. Rottem,et al.  Phospholipid and cholesterol uptake by Mycoplasma cells and membranes. , 1980, Biochimica et biophysica acta.

[18]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[19]  K. Dybvig,et al.  EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis. , 2013, FEMS microbiology letters.

[20]  A. Barron,et al.  Comparing bacterial membrane interactions of antimicrobial peptides and their mimics. , 2010, Methods in molecular biology.

[21]  M. Miyata.  Centipede and inchworm models to explain Mycoplasma gliding. , 2008, Trends in microbiology.

[22]  M J Ferraro.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[23]  R. Lehrer,et al.  Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory. , 1997, Methods in molecular biology.

[24]  R. Lehrer,et al.  Designer Assays for Antimicrobial Peptides , 1997 .

[25]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .